Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade. Maubec E. Br J Dermatol 2025 Aug 21:ljaf331. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maubec E. Avelumab plus cetuximab in advanced cutaneous squamous cell carcinoma: a strategy to overcome resistance to PD-1 blockade. Br J Dermatol 2025 Aug 21:ljaf331. doi: 10.1093.
PMID: 40838805